(Q68536818)
English
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results
scientific article published on 01 September 1990
Statements
Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15 (English)
B Fisher
A M Brown
N V Dimitrov
R Poisson
C Redmond
R G Margolese
D Bowman
N Wolmark
D L Wickerham
1 September 1990